P
NXTC icon

Pfizer’s NextCure NXTC Stock Holding History

Pfizer’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Sell
153,354
-4,292
-3% -$52.4K 0.64% 13
2025
Q4 		$2.24M Hold
157,646
– – 0.95% 12
2025
Q3 		$924K Buy
157,646
+144,509
+1,100% +$756K 0.21% 15
2025
Q2 		$870K Sell
13,137
-144,510
-92% -$776K 0.15% 16
2025
Q1 		$909K Buy
157,647
+36,101
+30% +$318K 0.18% 17
2024
Q4 		$1.89M Buy
+121,546
New +$1.79M 0.07% 18

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Pfizer's NXTC Position: Q1 2026 in Review

Pfizer reduced its NextCure (NXTC) stake by 2.7% in Q1 2026, selling an estimated $52.4K and leaving 153,354 shares worth $1.54M. The position accounts for 0.64% of the portfolio, ranked #13.

Pfizer first reported a position in NXTC in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.24M in Q4 2025. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • Pfizer held 153,354 shares of NextCure worth $1.54M as of Q1 2026.
  • Pfizer sold 4,292 NextCure shares in Q1 2026, an estimated $52.4K.
  • NextCure made up 0.64% of Pfizer's portfolio in Q1 2026, its #13 holding.
  • Pfizer first reported a position in NextCure in Q4 2024 and has held it in 6 quarters since.
  • Pfizer's NextCure position peaked at $2.24M in Q4 2025.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Pfizer's 13F filing for Q1 2026, filed 12 May 2026.